To investigate the progression-free survival (PFS) and the overall survival (OS) in a population affected by primary brain tumors (PBT) evaluated by [18F]-L-dihydroxyphenylalanine ([18F] FDOPA) positron emission tomography/computed tomography (PET/CT).
Chiaravalloti, A., Esposito, V., Ursini, F., Di Giorgio, E., Zinzi, M., Calabria, F., et al. (2019). Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?. ANNALS OF NUCLEAR MEDICINE [10.1007/s12149-019-01355-8].
Overall survival and progression-free survival in patients with primary brain tumors after treatment: is the outcome of [18F] FDOPA PET a prognostic factor in these patients?
Chiaravalloti, Agostino;Esposito, Vincenzo;Schillaci, Orazio
2019-04-04
Abstract
To investigate the progression-free survival (PFS) and the overall survival (OS) in a population affected by primary brain tumors (PBT) evaluated by [18F]-L-dihydroxyphenylalanine ([18F] FDOPA) positron emission tomography/computed tomography (PET/CT).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
OverallSurvivalAndProgression-.pdf
accesso aperto
Descrizione: Articolo
Licenza:
Copyright dell'editore
Dimensione
1.8 MB
Formato
Adobe PDF
|
1.8 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
